Qi Fu Yin ameliorates neuroinflammation through inhibiting RAGE and TLR4/NF-κB pathway in AD model rats

Author:

He Chunxiang12,Yu Wenjing12,Yang Miao12,Li Ze12,Yu Jingping23,Zhong Dayuan24,Deng Sisi12,Song Zhenyan12,Cheng Shaowu12

Affiliation:

1. School of Integrated Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha, Hunan 410208, China

2. Key Laboratory of Hunan Province for Integrated Traditional Chinese and Western Medicine on Prevention and Treatment of Cardio-Cerebral Diseases, College of Integrated Traditional Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha, Hunan 410208, China

3. Baoshan College of Traditional Chinese Medicine, Baoshan, Yunnan 678000, China

4. Guangdong Provincial Hospital of Integrated Traditional Chinese and Western Medicine, Foshan, Guangdong 528000, China

Publisher

Impact Journals, LLC

Subject

Cell Biology,Aging

Reference67 articles.

1. Alzheimer's disease.;Hodson;Nature,2018

2. The cost of Alzheimer's disease in China and re-estimation of costs worldwide.;Wu;Alzheimers Dement,2018

3. The current landscape in Alzheimer's disease research and drug discovery.;Devenish;Drug Discov Today,2020

4. Can we learn lessons from the FDA's approval of aducanumab?;Howard;Nat Rev Neurol,2021

5. A survey of TCM treatment for Alzheimer's disease.;Hu;J Tradit Chin Med,2007

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3